A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 8,025 shares of INCY stock, worth $552,441. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,025
Previous 8,445 4.97%
Holding current value
$552,441
Previous $511,000 3.72%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $24,078 - $28,816
-420 Reduced 4.97%
8,025 $530,000
Q2 2024

Aug 12, 2024

SELL
$51.18 - $63.75 $682,280 - $849,851
-13,331 Reduced 61.22%
8,445 $511,000
Q1 2024

May 15, 2024

SELL
$56.55 - $66.59 $1.09 Million - $1.28 Million
-19,247 Reduced 46.92%
21,776 $1.24 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $621,225 - $764,502
11,910 Added 40.91%
41,023 $2.58 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $1.04 Million - $1.19 Million
18,050 Added 163.16%
29,113 $1.68 Million
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $137,747 - $170,652
2,260 Added 25.67%
11,063 $689,000
Q1 2023

May 09, 2023

SELL
$70.23 - $86.01 $784,469 - $960,731
-11,170 Reduced 55.93%
8,803 $636,000
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $19,192 - $24,029
-290 Reduced 1.43%
19,973 $1.33 Million
Q2 2022

Aug 16, 2022

BUY
$66.18 - $83.18 $15,883 - $19,963
240 Added 1.2%
20,263 $1.54 Million
Q1 2022

May 17, 2022

SELL
$66.02 - $79.71 $70,113 - $84,652
-1,062 Reduced 5.04%
20,023 $1.59 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $195,720 - $228,999
3,090 Added 17.17%
21,085 $1.55 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $17,571 - $19,256
220 Added 1.24%
17,995 $1.51 Million
Q1 2021

May 14, 2021

BUY
$76.02 - $100.5 $65,377 - $86,430
860 Added 5.08%
17,775 $1.45 Million
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $657,223 - $795,278
8,140 Added 92.76%
16,915 $1.47 Million
Q3 2020

Nov 12, 2020

SELL
$85.07 - $109.69 $125,052 - $161,244
-1,470 Reduced 14.35%
8,775 $787,000
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $411,699 - $604,561
5,550 Added 118.21%
10,245 $1.07 Million
Q1 2020

May 14, 2020

BUY
$63.18 - $85.97 $138,680 - $188,704
2,195 Added 87.8%
4,695 $344,000
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $182,600 - $239,300
2,500 New
2,500 $218,000
Q3 2019

Nov 13, 2019

SELL
$72.82 - $86.52 $182,049 - $216,300
-2,500 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$73.52 - $88.7 $315,400 - $380,523
-4,290 Reduced 63.18%
2,500 $212,000
Q1 2019

May 14, 2019

BUY
$63.56 - $88.17 $431,572 - $598,674
6,790 New
6,790 $584,000
Q1 2018

May 14, 2018

SELL
$83.06 - $100.98 $181,901 - $221,146
-2,190 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$109.15 - $138.27 $239,038 - $302,811
2,190
2,190 $256,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Meiji Yasuda Asset Management CO Ltd. Portfolio

Follow Meiji Yasuda Asset Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.